Why is Covid-19 epidemics no so intense in Africa?

被引:7
|
作者
Villalonga-Morales, A. [1 ]
机构
[1] Ctr Hosp Mere & Enfant Monkole, Kinshasa, DEM REP CONGO
来源
关键词
D O I
10.1016/j.redar.2020.05.011
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:556 / 558
页数:3
相关论文
共 50 条
  • [41] The Paradox of COVID-19 in Sub-Saharan Africa: Why it is More Unethical Not to Investigate Low Dose Radiotherapy for COVID-19
    Mortazavi, Seyed Alireza
    Bevelacqua, Joseph J.
    Welsh, James S.
    Masoumi, Seyed Jalil
    Zarandi, Batool Faegheh Bahaaddini Beigy
    Ghadimi-Moghadam, Abdolkarim
    Haghani, Masoud
    Mortazavi, Seyed Mohammad Javad
    Journal of Biomedical Physics and Engineering, 2022, 12 (05): : 539 - 542
  • [42] The Case for Why Africa Should Host COVID-19 Candidate Vaccine Trials
    Singh, Jerome Amir
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (03): : 351 - 355
  • [43] Covid-19: Why Virtual Learning Becomes a Pedagogical Acceptance Model in Africa
    James, Nubi
    Vincent, Olufunke Rebecca
    Akande, Noah Oluwatobi
    Makinde, Ayodeji Samuel
    INTERNATIONAL JOURNAL OF EMERGING TECHNOLOGIES IN LEARNING, 2022, 17 (01) : 206 - 223
  • [44] COVID-19 research in Africa
    Bekker, Linda-Gail
    Mizrahi, Valerie
    SCIENCE, 2020, 368 (6494) : 919 - +
  • [45] Africa, Prisons and COVID-19
    Muntingh, Lukas M.
    JOURNAL OF HUMAN RIGHTS PRACTICE, 2020, 12 (02) : 284 - 292
  • [46] Experiences of COVID-19 in Africa
    Patrick Opoku Asuming
    Nature Human Behaviour, 2021, 5 : 546 - 547
  • [47] Understanding COVID-19 in Africa
    Tessema, Sofonias K.
    Nkengasong, John N.
    NATURE REVIEWS IMMUNOLOGY, 2021, 21 (08) : 469 - 470
  • [48] COVID-19 and cancer in Africa
    Addai, Beatrice Wiafe
    Ngwa, Wilfred
    SCIENCE, 2021, 371 (6524) : 25 - 27
  • [49] Experiences of COVID-19 in Africa
    Asuming, Patrick Opoku
    NATURE HUMAN BEHAVIOUR, 2021, 5 (05) : 546 - 547
  • [50] Africa in the Path of Covid-19
    El-Sadr, Wafaa M.
    Justman, Jessica
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (03):